Ophthalmology
April 2005
Objective: To evaluate the use of the intracorneal ring (ICR; Intacs, Addition Technology, Inc., Fremont, CA) for the treatment of pellucid marginal degeneration (PMD).Design: Case series.
© LitMetric 2024. All rights reserved.